Nanotechnologies for designing new medicines;Les nanotechnologies pour la conception de nouveaux médicaments

Biologie Aujourd'hui

Volumn 206, Issue 4, 2012, Pages 237-248

  Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

Author keywords

Cancer; Liposomes; Nanocarriers; Nanoparticles; Nanotechnologies

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; LIPOSOME; NANOCAPSULE; NANOPARTICLE; POLYMER;

ANIMAL; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; METHODOLOGY; MULTIDRUG RESISTANCE; NANOTECHNOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; HUMANS; LIPOSOMES; NANOCAPSULES; NANOPARTICLES; NANOTECHNOLOGY; POLYMERS;

EID: 84874254934     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2012025     Document Type: Article

References (28)

1. Al Khouri F.H., Roblot-Treupel L., Devissaguet J.P., Puisieux F., An original procedure for preparing nanocapsules of polyalkylcyanoacrylates for interfacial polymerization. Pharm Acta Helv, 1986, 61, 274-281. (Pubitemid 17196898)
2. Arias J.L., Reddy L.H., Othman M., Gillet B., Desmaële D., Zouhiri F., Dosio F., Gref R., Couvreur P., Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS Nano, 2011, 22, 1513-1521.
3. Barraud L., Merle P., Soma E., Lefrançois L., Guerret S., Chevallier M., Dubernet C., Couvreur P., Trépo C., Vitvitski L., Increase of doxorubicin sensitivity by doxorubicin loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepathology, 2005, 42, 736-743.
4. Bekkara-Aounallah F., Gref R., Othman M., Reddy L.H., Pili B., Allain V., Bourgaux C., Hillaireau H., Lepêtre-Mouelhi S., Desmaële D., Nicolas J., Chafi N., Couvreur P., Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues. Adv Funct Materials, 2008, 18, 3715-3725.
5. Bildstein L., Dubernet C., Marsaud V., Chacun H., Nicolas V., Gueutin C., Sarasin A., Bénech H., Lepêtre-Mouelhi S., Desmaële D., Couvreur P., Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: An original drug delivery pathway. J Control Rel, 2010, 147, 163-170.
6. Brigger I., Morizet J., Aubert G., Chacun H., Terrier-Lacombe M.J., Couvreur P., Vassal G., Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther, 2002, 303, 928-936. (Pubitemid 35424373)
7. Calvo P., Gouritin B., Villarroya H., Eclancher F., Giannavola C., Klein C., Andreux J.P., Couvreur P., Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur J Neurosci, 2002, 15, 1317-1326. (Pubitemid 35477993)
8. Chiannilkulchai N., Ammoury B., Caillou J.P., Devissaguet P., Couvreur P., Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M5076 metastasis-bearing mice. Cancer Chemother Pharmacol, 1990, 26, 122-126. (Pubitemid 20153803)
9. Colin de Verdière A., Dubernet C., Némati F., Soma E., Appel M., Ferté J., Bernard S., Puisieux F., Couvreur P., Reversion of the multidrug resistance with polyalkylcyanoacrylate nanoparticles: mechanism of action. Brit J Cancer, 1997, 76, 198-205. (Pubitemid 27279659)
10. Couvreur P., Les nanotechnologies peuvent-elles contribuer à traiter des maladies sévères Leçon inaugurale du Collège de France, Fayard 2010.
11. Couvreur P., Tulkens P., Roland M., Trouet A., Speiser P., Nanocapsules: a new type of lysosomotropic carrier., FEBS Lett, 1977, 84, 323-326. (Pubitemid 8246984)
12. Couvreur P., Stella B., Reddy L.H., Hillaireau H., Dubernet C., Desmaële D., Lepêtre-Mouelhi S., Rocco F., Dereuddre-Bosquet N., Clayette P., Rosilio V., Marsaud V., Renoir M., Cattel L., Squalenoyl nanomedicines as potential therapeutics. Nano Lett, 2006, 6, 2544-2548. (Pubitemid 46076946)
13. Couvreur P., Reddy L.H., Mangenot S., Poupaert J.H., Desmaële D., Lepêtre-Mouelhi S., Pili B., Bourgaux C., Amenitsch H., Ollivon M., Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue. Small, 2008, 42, 247-53. (Pubitemid 351271158)
14. de Martimprey H., Bertrand J.R., Fusco A., Santoro M., Couvreur P., Vauthier C., Malvy C., siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucl Ac Res, 2008, 36, 1093-1094.
15. Gabizon A.A., Barenholz Y., Bialer M., Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharm Res, 1993, 10, 703-708. (Pubitemid 23152316)
16. Gregoriadis G., Leathwood P.D., Ryman B.E., Enzyme entrapment in liposomes. FEBS Lett, 1971, 14, 95-99.
17. Hillaireau H., Couvreur P., Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci, 2009, 66, 2873-2896.
18. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., Eubank J.F., Heurtaux D., Clayette P., Kreuz C., Chang J.S., Hwang Y.K., Marsaud V., Bories P.N., Cynober L., Gil S., Férey G., Couvreur P., Gref R., Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nature Mater, 2010, 9, 172-178.
19. Karatas H., Aktas Y., Gursoy-Ozdemir Y., Bodur E., Yemisci M., Caban S., Vural A., Pinarbasli O., Capan Y., Fernandez-Megia E., Novoa-Carballal R., Riguera R., Andrieux K., Couvreur P., Dalkara T., A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. - J Neurosci, 2009, 29, 13761-13769.
20. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., Kataoka K., Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res, 2003, 63, 8977-8983. (Pubitemid 38064079)
21. Mullard A., 2011 FDA drug approvals. Nat Rev Drug Discov, 2012, 11, 91.
22. Peracchia M.T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.C., Desmaële D., d'Angelo J., Müller R.H., Couvreur P., Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials, 1999, 20, 14, 1269 - 1275. (Pubitemid 29281378)
23. Reddy L.H., Marque P.E., Dubernet C., Lepêtre-Mouelhi S., Dësmaele D., Couvreur P., Preclinical toxicology (sub-acute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine. J Pharm Exp Ther, 2008, 325, 484-490. (Pubitemid 351574820)
24. Reddy L.H., Renoir J.M., Marsaud V., Lepêtre-Mouelhi S., Dësmaele D., Couvreur P., Anticancer efficacy of squalenoyl Gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. Mol Pharm, 6, 2009, 1526-1535.
25. Scatton B., Le processus de découverte du médicament dans l'industrie pharmaceutique. J Soc Biol, 2009, 203, 249-269.
26. Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., Hoebeke J., Duguet E., Colombo P., Couvreur P., Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem, 2005, 16, 1181-1188. (Pubitemid 41368119)
27. Torchilin V., Multifunctional nanocarriers. Adv Drug Del Rev, 2006, 58, 1532-1555. (Pubitemid 44822608)
28. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta, 1992, 1105, 193 - 200.